The long awaited consolidation of French imaging is set to ramp up, especially in the attractive fields of radiology and teleradiology, according to French sources.
London-based PE group Apposite Capital is among the most active investors in health care in Europe. HBI chats with managing partner Sam Gray about the state of the market and pricing, how he sees that changing, and the investment opportunities piquing his interest at present.
German health minister Karl Lauterbach’s attempt to stop “locust investors” from owning outpatient facilities could actually end up benefitting large PE firms. HBI speaks to sources in Germany to find out more.
HBI hears German health minister Karl Lauterbach’s plan to stop “locust investors” from buying up outpatient facilities may be shot down by a double whammy of legal and political considerations. HBI speaks to a Germany-based lawyer and healthcare expert to find out more.
Elderly care group Attendo and outpatient group Terveystalo, two pan-Nordic giants with over a billion in revenue, struggled to turn a profit in 2022. This was despite strong (organic) revenue growth, set against a backdrop of rising inflation. HBI looks at the newly released results of both groups to find out more.
Sources at the Arab Health exhibition confirm that the ambitious Saudi 2030 project which will see the country transfer most health care service delivery to the for-profit sector is still on. What are the implications of this?
German health minister Karl Lauterbach offered a politicised Christmas present in December with an announcement he would stop “locust investors” buying up outpatient medical practices. A German VC source tells HBI this could “kill” private equity investment in German healthcare, and push innovation elsewhere.
Pressure is growing for a change in German law restricting who can invest in healthcare. If enacted, it could effectively see some outpatient operators “banned”, and restrict who can do telehealth. Is such a development likely? HBI speaks to a trio of German healthcare experts to find out more.
In April last year, medical device giant Siemens Healthineers acquired Varian Medical Systems in one of the largest all cash MedTech transactions in history. HBI catches up with Varian CEO Chris Toth to find out more about the deal, and Varian’s plans for the future.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy
